Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the listing Regulations we wish to inform you that the Board of Directors of the Company at its meeting held today has approved the unaudited Financial Results for third quarter and nine months ended December 31 2019.
The above financial Results along with the Limited Review Report on the Financial Results are enclosed herewith.
The meeting of the Board of Directors was concluded at 5.15 p.m.
Aspira Pathlab & Diagnostics: Outcome Of Meeting Of The Board Of Directors Of Aspira Pathlab & Diagnostics Limited Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Regulations').
04-Feb-2020
Download PDF
Aspira Pathlab
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month